The Ensign Group (ENSG) concentration risks

The company's concentration profile combines a high-share product-type tilt with dual government-payer dependencies, all interconnected by the nature of the skilled nursing facility business. The most dominant structural feature is product concentration: approximately 95.6% of revenue is generated from skilled nursing facilities, a high-share exposure that defines the entire operating model. There is effectively no product diversification disclosed in the filing. Layered on top of that product concentration are two government payer exposures. Medicaid is the largest source of revenue, accounting for 45.8% of revenue for the year ended December 31, 2025 — a medium-share mixed exposure where the structural element is that elderly long-term care is predominantly government-funded, and the dependency element is that Medicaid reimbursement rates are set by individual state legislatures and can change. Medicare, the second government payer, contributed 23.7% of service revenue — a low-share mixed exposure subject to federal policy and reimbursement rate decisions. Together, Medicaid and Medicare make up the large majority of disclosed revenue, meaning federal and state government reimbursement policy is the single most important external variable affecting financial results. The product concentration in skilled nursing amplifies this payer dependency: the company cannot easily redirect its assets to a different business model if government reimbursement rates compress. These exposures are well-disclosed and the most verdict-relevant risks in the profile.

For the engine’s reasoning on ENSG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.